Please assess the completion status of the following clinical trial:

Trial Title: Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18, ≤64 years~* Physician-diagnosis of asthma~* Regular inhaled budesonide (Giona Easyhaler, Pulmicort Turbuhaler, Novopulmon Novolizer or Symbicort Turbuhaler) treatment since at least 6 months~* Verified allergy to at least one airborne perennial allergen after objective testing (ImmunoCAP Rapid Asthma/Rhinitis Adult)~* ACQ \>1.0~* Can read and understand the Swedish language~* Written informed consent signed~Exclusion Criteria:~* Regular tobacco use within past 6 months~* ≥10 pack-years smoking history~* Keeping a furred pet at home~* Treatment with Singulair~* \>4 prednisolone courses last 12 months~* Ongoing pregnancy or lactation~* Participation in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Budesonide (Type: OTHER): Asthma treated patient with Budesonide for 1 year, 4 different dosage according to measurement of exhaled NO done with NIOX MINO.
- Standard of care (Type: NO_INTERVENTION): Asthma treated patient with standard of care during 1 year. Exhaled NO measurement will be done 4 times/year, and compared afterwards with the Budesonide group.

Based on this trial design, predict the completion outcome and termination type (if applicable).